Brand profile · Biotechnology Research

Canary Regulatory Affairs

Canary Regulatory Affairs is a Biotechnology Research brand in Melbourne. Ownership is privately held; it publishes at canaryregulatory.com. It holds two addresses on record, all in Australia. The record counts 4 people. Tagged quality. One Australian registration (ABN) is a confirmed match. It is listed alongside seven similar brands, mostly in Business Consulting.

canaryregulatory.com LinkedIn

Profile live Privately Held Founded 2020 1 entity ABN 1 office country
Registry verified · ABR
Counted staff
4
self-reported 1–1 band
Founded
2020
6 years
Legal entities
1
ABR
Office countries
1
2 addresses
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

  • CANARY REGULATORY AFFAIRS PTY LTD

    ABN47643191897

    VICHigh confidenceMatched on exact nameABR

Legal entities

Canary Regulatory Affairs: 1 registry entityCanary Regulatory Affairs is linked to 1 registry entity: CANARY REGULATORY AFFAIRS PTY LTD (ABN 47643191897, candidate).Canary Regulatory AffairsCANARY REGULATORYAFFAIRS PTY LTDABN 47643191897Candidate · High confidence
Show as table
CANARY REGULATORY AFFAIRS PTY LTDABN 47643191897
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Canary Regulatory Affairs provides expert Product Development and Global Regulatory Affairs strategic advice and operational support to pharmaceutical, biotechnology, and medical device companies.

Our mission is to expedite the registration and commercialization of our clients’ products, ensuring they can meet patient needs in a timely fashion.

We partner with clients through every phase of the development journey, from concept to regulatory approval. As seasoned industry professionals, we understand the challenges our clients face and are committed to finding effective solutions.

Our comprehensive expertise spans:

  • Quality: from formulation to manufacturing and process validation.
  • Non-Clinical: design and project management of in vitro and in vivo and toxicology studies.
  • Clinical: Protocol development, investigator brochure preparation, and clinical study report writing.

Canary ensures seamless global product registration by fostering early dialogue with international regulatory authorities. With extensive experience working with the European Medicines Agency, National Competent Authorities in Europe, the U.S. FDA, and Australia’s TGA, we help our clients ask the right questions, overcome regulatory hurdles, and resolve challenges through skilled negotiation. Our belief in fostering constructive relationships with all stakeholders ensures smooth pathways to problem-solving.

We work closely with clients to define clear objectives and create tailored strategies to achieve them within ambitious yet realistic timeframes. Recognizing that resources can be limited, we offer flexible support that integrates seamlessly with in-house teams.

At Canary, we take pride in delivering high-quality, timely results, treating every client project with the same care and dedication as if it were our own.

Specialties

All 17 specialties
  • Investigational New Drug (IND) application
  • Marketing Authorisation Application (MAA) and New Drug Application (NDA) Common Technical Documents (CTD) Modules
  • Scientific Advice/Protocol Assistance briefing packages
  • Paediatric Investigational Plans (PIP)
  • Orphan Drug Designation (ODD) applications
  • Named Patient Programs (NPP) applications
  • Background Documents for FDA Type C
  • Pre-IND and Pre-NDA meetings
  • Accelerated Pathways designation applications
  • Responses to regulatory questions/Information Requests
  • Quality and Non-clinical gap analysis
  • Quality
  • Non-Clinical and Clinical study protocol design
  • Clinical Trial Applications (CTAs)
  • ASMF/DMF review and preparation support
  • Product Information
  • Labelling and Packaging design

Related specialties

Locations

Australiaprimary

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUMelbournePrimary
  • AUBentleigh East , VIC 3165

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

2 employee profiles on record · names withheld.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Canary Regulatory Affairs?

One Victoria entity on the ABR. CANARY REGULATORY AFFAIRS PTY LTD (ABN 47 643 191 897), high confidence.

How many people work at Canary Regulatory Affairs?

The record holds 4 counted staff profiles at January 2026, above the self-reported 1 band.

Where does Canary Regulatory Affairs have offices?

Two addresses on record, Australia only. Primary: Melbourne.

Has Canary Regulatory Affairs raised funding?

None linked to this brand.

What does Canary Regulatory Affairs list as its specialties?

17 tags on the brand's own list, among them quality.

Which companies are listed alongside Canary Regulatory Affairs?

Seven peer profiles on record: MedWise Consulting and RFA Regulatory Affairs.

What is Canary Regulatory Affairs's website?

canaryregulatory.com